Evidence map›Paper›PMID 37709791›Full record

ArticleScientific reports2023

Telemedicine retinopathy of prematurity severity score (TeleROP-SS) versus modified activity score (mROP-ActS) retrospective comparison in SUNDROP cohort.

Christine L Xu, Joel Adu-Brimpong, Henry P Moshfeghi, Tatiana R Rosenblatt, Michael D Yu, Marco H Ji, Sean K Wang, Moosa Zaidi, Hashem Ghoraba, Suzanne Michalak and 8 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Scientific reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. P-Score Variability as a Function of Retinopathy of Prematurity Severity.Investigative ophthalmology & visual science · 2026
    Article
  4. Observational
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Christine L XuDepartment of Ophthalmology, Horngren Family Vitreoretinal Center, Byers Eye Institute, Stanford University School of Medicine, 2452 Watson Ct., Rm 2277, Palo Alto, CA, 94303, USA.
Joel Adu-BrimpongDepartment of Ophthalmology, Horngren Family Vitreoretinal Center, Byers Eye Institute, Stanford University School of Medicine, 2452 Watson Ct., Rm 2277, Palo Alto, CA, 94303, USA.
Henry P MoshfeghiCarleton College, Northfield, MN, USA.
Tatiana R RosenblattDepartment of Ophthalmology, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, MA, USA.
Michael D YuDepartment of Ophthalmology, Horngren Family Vitreoretinal Center, Byers Eye Institute, Stanford University School of Medicine, 2452 Watson Ct., Rm 2277, Palo Alto, CA, 94303, USA.
Marco H JiDepartment of Ophthalmology, Jones Eye Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
Sean K WangDepartment of Ophthalmology, Horngren Family Vitreoretinal Center, Byers Eye Institute, Stanford University School of Medicine, 2452 Watson Ct., Rm 2277, Palo Alto, CA, 94303, USA.
Moosa ZaidiDepartment of Ophthalmology, Horngren Family Vitreoretinal Center, Byers Eye Institute, Stanford University School of Medicine, 2452 Watson Ct., Rm 2277, Palo Alto, CA, 94303, USA.
Hashem GhorabaDepartment of Ophthalmology, Horngren Family Vitreoretinal Center, Byers Eye Institute, Stanford University School of Medicine, 2452 Watson Ct., Rm 2277, Palo Alto, CA, 94303, USA.
Suzanne MichalakDepartment of Ophthalmology, Horngren Family Vitreoretinal Center, Byers Eye Institute, Stanford University School of Medicine, 2452 Watson Ct., Rm 2277, Palo Alto, CA, 94303, USA.
Natalia F CallawayDepartment of Ophthalmology, Horngren Family Vitreoretinal Center, Byers Eye Institute, Stanford University School of Medicine, 2452 Watson Ct., Rm 2277, Palo Alto, CA, 94303, USA.
Jochen KummDepartment of Ophthalmology, Horngren Family Vitreoretinal Center, Byers Eye Institute, Stanford University School of Medicine, 2452 Watson Ct., Rm 2277, Palo Alto, CA, 94303, USA.
Eric NudlemanViterbi Family Department of Ophthalmology, Shiley Eye Institute, University of California San Diego, La Jolla, CA, USA.
Edward H WoodAustin Retina Associates, Austin, TX, USA.
Nimesh A PatelDepartment of Ophthalmology, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, MA, USA.
Andreas StahlDepartment of Ophthalmology, University Medicine Greifswald, Greifswald, Germany.
Domenico LeporeDepartment of Geriatrics and Neuroscience, Catholic University of the Sacred Heart, A. Gemelli Foundation IRCSS, Rome, Italy.
Darius M MoshfeghiDepartment of Ophthalmology, Horngren Family Vitreoretinal Center, Byers Eye Institute, Stanford University School of Medicine, 2452 Watson Ct., Rm 2277, Palo Alto, CA, 94303, USA. dariusm@stanford.edu.

Funding

Stanford Vision Research CoreP30EY026877 · NEI · STANFORD UNIVERSITY · PI Jeffrey L Goldberg · 2017 to 2026
$8.0M
NEI NIH HHS P30 EY026877
6 · The paper itself

Abstract

Identifying and planning treatment for retinopathy of prematurity (ROP) using telemedicine is becoming increasingly ubiquitous, necessitating a grading system to help caretakers of at-risk infants gauge disease severity. The modified ROP Activity Scale (mROP-ActS) factors zone, stage, and plus disease into its scoring system, addressing the need for assessing ROP's totality of binocular burden via indirect ophthalmoscopy. However, there is an unmet need for an alternative score which could facilitate ROP identification and gauge disease improvement or deterioration specifically on photographic telemedicine exams. Here, we propose such a system (Telemedicine ROP Severity Score [TeleROP-SS]), which we have compared against the mROP-ActS. In our statistical analysis of 1568 exams, we saw that TeleROP-SS was able to return a score in all instances based on the gradings available from the retrospective SUNDROP cohort, while mROP-ActS obtained a score of 80.8% in right eyes and 81.1% in left eyes. For treatment-warranted ROP (TW-ROP), TeleROP-SS obtained a score of 100% and 95% in the right and left eyes respectively, while mROP-ActS obtained a score of 70% and 63% respectively. The TeleROP-SS score can identify disease improvement or deterioration on telemedicine exams, distinguish timepoints at which treatments can be given, and it has the adaptability to be modified as needed.

Indexed as

Retinopathy of PrematurityTelemedicineEyeHumansInfantInfant, NewbornOphthalmoscopyRetrospective Studies

Identifiers

PMID37709791
PMCPMC10502047

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.